| Total No. of Records -6399 Page - 1 of 640 | |||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
| Latest Corporate News | |
![]() |
Eurocor GmbH to Make Catheters for Heart Diseases Eurocor GmbH has entered into a licensing agreement with Biosensors International Group Ltd to manufacture catheters for treating heart diseases. Eurocor is a group firm of medical technology leader Opto Circuits India Ltd. As part of th... |
![]() |
Esperion Therapeutics Has Raised $33 Million to Finance Clinical Trials American biotech company Esperion Therapeutics revealed that it has managed to raise $33 million through preferred stock financing which will be used on clinical trials. The Ann Arbor based company is currently in midst of the phase II trial... |
![]() |
Phase 1 Clinical Trial Reveals Positive Data for BIND Theraputics’ Drug for Solid Tumors Presenting the data at the American Association for Cancer Research (AACR) 2013 Annual Meeting, biopharmaceutical company BIND Therapeutics revealed that phase 1 clinical data for BIND-014, the company’s leading drug candidate, have been positive. |
![]() |
Cancer Breakthrough Reported by Novogen Australian drug company Novogen Limited revealed that it has succeeded in isolating the most potent form of its lead anti-cancer drug candidate, CS-6. Novogen revealed that CS-6 is a chiral molecule, a molecule that has a non-superposable mi... |
![]() |
Opto Circuits Agrees to Sell Diagnostic Cardiology Products to Mortara Instrument Mortara Instrument Inc. of Milwaukee has signed an agreement to acquire the cardiac diagnostic product line from Cardiac Science, which is a part of Opto Circuits. Cardiac Science has agreed to offer its support to diagnostic cardiology b... |
| More Corporate News | |
|
|||||
